Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (9)

2019

  1. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

    American Journal of Ophthalmology, Vol. 200, pp. 85-94

2017

  1. Anti–Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis–Associated Uveitis Refractory to Anti–Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients

    Arthritis and Rheumatology, Vol. 69, Núm. 3, pp. 668-675

2015

  1. Clinical and genetic features of Spanish patients with Mevalonate kinase deficiency

    Pediatric Rheumatology, Vol. 13, Núm. 1

  2. Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset

    Rheumatology International, Vol. 35, Núm. 10, pp. 1615-1624

2009

  1. NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: Study of an international registry and a national cohort in Spain

    Arthritis and Rheumatism, Vol. 60, Núm. 6, pp. 1797-1803

2007

  1. NOD2 gene-associated pediatric granulomatous arthritis: Clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort

    Arthritis and Rheumatism, Vol. 56, Núm. 11, pp. 3805-3813

  2. Qué es lo que hoy debo saber sobre los síndromes autoinflamatorios?

    Seminarios de la Fundacion Espanola de Reumatologia, Vol. 8, Núm. 1, pp. 34-44

2004

  1. Chronic infantile neurological cutaneous and articular syndrome: A new case with pseudotumor cerebri

    Neuro-Ophthalmology, Vol. 28, Núm. 4, pp. 187-190

  2. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene

    Arthritis and Rheumatism, Vol. 50, Núm. 12, pp. 4045-4050